Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial

OBJECTIVES: We aimed at assessing the efficacy and safety on antibiotic exposure of a strategy combining a respiratory multiplex PCR (mPCR) with enlarged panel and daily procalcitonin (PCT) measurements, as compared with a conventional strategy, in adult patients who were critically ill with laborat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fartoukh, Muriel, Nseir, Saad, Mégarbane, Bruno, Cohen, Yves, Lafarge, Antoine, Contou, Damien, Thille, Arnaud W., Galerneau, Louis-Marie, Reizine, Florian, Cour, Martin, Klouche, Kada, Navellou, Jean-Christophe, Bitker, Laurent, Rousseau, Alexandra, Tuffet, Sophie, Simon, Tabassome, Voiriot, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847221/
https://www.ncbi.nlm.nih.gov/pubmed/36681325
http://dx.doi.org/10.1016/j.cmi.2023.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847221/
https://www.ncbi.nlm.nih.gov/pubmed/36681325
http://dx.doi.org/10.1016/j.cmi.2023.01.009

Ejemplares similares